Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Camilla H. Stokkevåg, Grete M. Engeseth, Liv B. Hysing, Kristian S. Ytre-Hauge, Christian Ekanger & Ludvig P. Muren. (2015) Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer. Acta Oncologica 54:9, pages 1317-1325.
Read now
Read now
Safora Johansen, Turi Danielsen & Dag Rune Olsen. (2008) Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer. Acta Oncologica 47:3, pages 391-396.
Read now
Read now
Articles from other publishers (31)
Camilla H. Stokkevåg, Neige Journy, Ivan R. Vogelius, Rebecca M. Howell, David Hodgson & Søren M. Bentzen. (2024) Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors. International Journal of Radiation Oncology*Biology*Physics 119:2, pages 681-696.
Crossref
Crossref
Marius Treutwein, Rainer Loeschel, Matthias Hipp, Oliver Koelbl & Barbara Dobler. (2020) Secondary malignancy risk for patients with localized prostate cancer after intensity‐modulated radiotherapy with and without flattening filter. Journal of Applied Clinical Medical Physics 21:12, pages 197-205.
Crossref
Crossref
Apostolos Raptis, Jakob Ödén, Oscar Ardenfors, Anna M. Flejmer, Iuliana Toma-Dasu & Alexandru Dasu. (2020) Cancer risk after breast proton therapy considering physiological and radiobiological uncertainties. Physica Medica 76, pages 1-6.
Crossref
Crossref
M. Mazonakis, J. Stratakis, E. Lyraraki & J. Damilakis. (2019) Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma. Physica Medica 60, pages 44-49.
Crossref
Crossref
M.P. Little. (2018) Evidence for dose and dose rate effects in human and animal radiation studies. Annals of the ICRP 47:3-4, pages 97-112.
Crossref
Crossref
Michalis Mazonakis, Antonis Tzedakis, Efrossyni Lyraraki & John Damilakis. (2018) Risk of developing radiogenic cancer following photon‐beam radiotherapy for Graves’ orbitopathy. Medical Physics 45:10, pages 4775-4782.
Crossref
Crossref
Van Tran & Mark P. Little. (2017) Dose and dose rate extrapolation factors for malignant and non-malignant health endpoints after exposure to gamma and neutron radiation. Radiation and Environmental Biophysics 56:4, pages 299-328.
Crossref
Crossref
Eva Bezak, Rundgham Takam, Eric Yeoh & Loredana G. Marcu. (2017) The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy. Physica Medica 42, pages 253-258.
Crossref
Crossref
Alexandru Dasu & Iuliana Toma-Dasu. (2017) Models for the risk of secondary cancers from radiation therapy. Physica Medica 42, pages 232-238.
Crossref
Crossref
M. Mazonakis & J. Damilakis. (2017) Cancer risk after radiotherapy for benign diseases. Physica Medica 42, pages 285-291.
Crossref
Crossref
Panayiotis Mavroidis, Georgios Komisopoulos, Courtney Buckey, Margarita Mavroeidi, Gregory P. Swanson, Dimos Baltas, Nikos Papanikolaou & Sotirios Stathakis. (2017) Radiobiological evaluation of prostate cancer IMRT and conformal-RT plans using different treatment protocols. Physica Medica 40, pages 33-41.
Crossref
Crossref
Michalis Mazonakis, Antonis Tzedakis, Efrossyni Lyraraki & John Damilakis. (2016) Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. Physics in Medicine and Biology 61:17, pages 6400-6412.
Crossref
Crossref
Camilla H. Stokkevåg, Mai Fukahori, Takuma Nomiya, Naruhiro Matsufuji, Grete May Engeseth, Liv B. Hysing, Kristian S. Ytre-Hauge, Eivind Rørvik, Artur Szostak & Ludvig P. Muren. (2016) Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy. Radiotherapy and Oncology 120:2, pages 300-306.
Crossref
Crossref
Uwe Schneider & Linda Walsh. (2015) Age at exposure and attained age variations of cancer risk in the Japanese A‐bomb and radiotherapy cohorts. Medical Physics 42:8, pages 4755-4761.
Crossref
Crossref
Georgios Komisopoulos, Panayiotis Mavroidis, Salvador Rodriguez, Sotirios Stathakis, Nikos Papanikolaou, Georgios C. Nikiforidis & Georgios C. Sakellaropoulos. (2014) Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks. Medical Dosimetry 39:4, pages 337-347.
Crossref
Crossref
A. Dasu & I. Toma-Dasu. 2014. Comprehensive Biomedical Physics. Comprehensive Biomedical Physics
223
233
.
Louise Murray, Ann Henry, Peter Hoskin, Frank-Andre Siebert & Jack Venselaar. (2013) Second primary cancers after radiation for prostate cancer: a review of data from planning studies. Radiation Oncology 8:1.
Crossref
Crossref
Brigitte Zurl, Heidi Stranzl, Peter Winkler & Karin Sigrid Kapp. (2013) Quantification of Contralateral Breast Dose and Risk Estimate of Radiation-Induced Contralateral Breast Cancer Among Young Women Using Tangential Fields and Different Modes of Breathing. International Journal of Radiation Oncology*Biology*Physics 85:2, pages 500-505.
Crossref
Crossref
Laura A Rechner, Rebecca M Howell, Rui Zhang, Carol Etzel, Andrew K Lee & Wayne D Newhauser. (2012) Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Physics in Medicine and Biology 57:21, pages 7117-7132.
Crossref
Crossref
Harald Paganetti, Basit S Athar, Maryam Moteabbed, Judith A Adams, Uwe Schneider & Torunn I Yock. (2012) Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Physics in Medicine and Biology 57:19, pages 6047-6061.
Crossref
Crossref
M. Uhl, F. Sterzing, G. Habl, K. Schubert, H. Holger, J. Debus & K. Herfarth. (2012) Breast cancer and funnel chestBrustkrebs und Trichterbrust. Strahlentherapie und Onkologie 188:2, pages 127-135.
Crossref
Crossref
Loredana Marcu, Eva Bezak & Barry AllenLoredana Marcu, Eva Bezak & Barry Allen. 2012. Biomedical Physics in Radiotherapy for Cancer. Biomedical Physics in Radiotherapy for Cancer
399
423
.
Harald PaganettiHarald Paganetti. 2011. Proton Therapy Physics. Proton Therapy Physics
555
592
.
Uwe Schneider, Marcin Sumila & Judith Robotka. (2011) Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Theoretical Biology and Medical Modelling 8:1.
Crossref
Crossref
Uwe Schneider. (2011) Modeling the Risk of Secondary Malignancies after Radiotherapy. Genes 2:4, pages 1033-1049.
Crossref
Crossref
Alexandru Daşu, Iuliana Toma-Daşu, Lars Franzén, Anders Widmark & Per Nilsson. (2011) Secondary Malignancies From Prostate Cancer Radiation Treatment: A Risk Analysis of the Influence of Target Margins and Fractionation Patterns. International Journal of Radiation Oncology*Biology*Physics 79:3, pages 738-746.
Crossref
Crossref
Uwe Schneider. (2009) Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Medical Physics 36:4, pages 1138-1143.
Crossref
Crossref
Martin Hillbrand, Dietmar Georg, Helmut Gadner, Richard Pötter & Karin Dieckmann. (2008) Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiotherapy and Oncology 89:2, pages 141-149.
Crossref
Crossref
Jeremy D. Ruben, Sidney Davis, Cherie Evans, Phillip Jones, Frank Gagliardi, Matthew Haynes & Alistair Hunter. (2008) The Effect of Intensity-Modulated Radiotherapy on Radiation-Induced Second Malignancies. International Journal of Radiation Oncology*Biology*Physics 70:5, pages 1530-1536.
Crossref
Crossref
Uwe Schneider & Linda Walsh. (2007) Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy. Radiation and Environmental Biophysics 47:2, pages 253-263.
Crossref
Crossref
Uwe Schneider, Antony Lomax, Jürgen Besserer, Peter Pemler, Norbert Lombriser & Barbara Kaser-Hotz. (2007) The Impact of Dose Escalation on Secondary Cancer Risk After Radiotherapy of Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 68:3, pages 892-897.
Crossref
Crossref